Maas, R. J., Hoogstad-van Evert, J. S., Van der Meer, J. M., Mekers, V., Rezaeifard, S., Korman, A. J., . . . Dolstra, H. (2020). TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer. Oncoimmunology.
Styl ChicagoMaas, Ralph Ja, et al. "TIGIT Blockade Enhances Functionality of Peritoneal NK Cells With Altered Expression of DNAM-1/TIGIT/CD96 Checkpoint Molecules in Ovarian Cancer." Oncoimmunology 2020.
Citace podle MLAMaas, Ralph Ja, et al. "TIGIT Blockade Enhances Functionality of Peritoneal NK Cells With Altered Expression of DNAM-1/TIGIT/CD96 Checkpoint Molecules in Ovarian Cancer." Oncoimmunology 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..